Open AccessThe effect of ‘cytochrome P-450 2C9’ and ‘vitamin K epoxide reductase complex 1’ genetic polymorphism upon oral anticoagulation requirements
Author(s) -
HossamY.K Mohammed,
YousryZ Al-Zohairy,
Mahmoud AbdEl-Latif Hashish
Publication year - 2018
Publication title -
al-azhar assiut medical journal
Language(s) - English
Resource type - Journals
eISSN - 2536-9652
pISSN - 1687-1693
DOI - 10.4103/azmj.azmj_91_18
Subject(s) - vkorc1 , vitamin k epoxide reductase , cyp2c9 , medicine , genotype , gastroenterology , reductase , vitamin , vitamin k antagonist , endocrinology , cytochrome p450 , warfarin , pharmacology , biology , enzyme , genetics , gene , biochemistry , atrial fibrillation , metabolism
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom